Boise, IDNCT05504837Now EnrollingIRB Ready

Cystic Fibrosis Clinical Trial in Boise, ID

Access cutting-edge cystic fibrosis treatment through this clinical trial at a research site in Boise. Study-provided care at no cost to qualified participants.

Sponsored by Krystal Biotech, Inc.

Quick Self-Assessment

See if you qualify for this Boise location

Preparing your pre-screening questions…

Expert Care in Boise

Access cystic fibrosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cystic fibrosis treatment provided free

Apply for This Boise Location

Check if you qualify for this cystic fibrosis clinical trial in Boise, ID

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boise

    Convenient for ID residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boise site if eligible
  4. 4Begin participation

About This Cystic Fibrosis Study in Boise

This study will evaluate safety and tolerability of ascending doses of nebulized KB407 in adults with cystic fibrosis.

Sponsor: Krystal Biotech, Inc.

Who Can Participate

Inclusion Criteria

The subject must have read, understood, and signed an Institutional Review Board/Ethics Committee (IRB/IEC) approved Informed Consent Form and must be able to and willing to follow study procedures and instructions
Subjects aged 18 years or older at the time of Informed Consent
A confirmed diagnosis of CF as defined by clinical signs and symptoms of CF and at least one of the following:
A historical sweat chloride value \>60 mmol/L
Two copies of a disease causing mutation in the CFTR gene
Clinically stable in the opinion of the Investigator
Percent predicted FEV1 ≥40% and ≤90% of the predicted normal for age, gender, and height at Screening
Resting oxygen saturation ≥92% on room air at Screening

Exclusion Criteria

Initiation of any new chronic therapy (eg, CFTR modulator, hypertonic saline, inhaled antibiotic) or any change in chronic therapy (excluding pancreatic enzyme replacement therapy) within 28 days prior to the first dose
Hospitalization, sinopulmonary infection, CF exacerbation, or other clinically significant infection or illness 14 days prior to the first dose that, in the opinion of the Investigator, may confound study results
Treatment for Mycobacterium abscessus within 3 months prior to the first dose or more than two pulmonary exacerbations with a history of Burkholderia cenocepacia infection within 6 months prior to the first dose
Participation in another clinical study or treatment with an investigational agent 30 days or 5 half-lives, whichever is longer, prior to the first dose
History of or listed for solid organ transplantation
Any condition (including a history or current evidence of substance abuse or dependence, uncontrolled asthma, or is considered to be immunocompromised) that, in the opinion of the Investigator, would impact a subject's ability to complete all study-related procedures and/or poses an additional risk to the assessment of safety of KB407
An active oral herpes infection 30 days prior to the first dose
Women who are pregnant or nursing
Subject who is unwilling to comply with contraception requirements per protocol
Clinically significant abnormalities of hematology or chemistry testing at Screening that the Investigator believes may interfere with the assessment of safety and/or efficacy of the study treatment
Subject has a known hypersensitivity to inhaled glycerol
Subject is known to be noncompliant or is unlikely to comply with the requirements of the study protocol in the opinion of the Investigator
Bronchoscopy participants only: Unable to tolerate bronchoscopy procedure and airway sampling, in the opinion of the Investigator
Cohort 4 participants only: Subjects who are ineligible for, do not tolerate, or do not benefit from modulator therapy

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boise?

Yes, this clinical trial (NCT05504837) has an active research site in Boise, ID that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cystic Fibrosis Treatment Options in Boise, ID

If you're searching for cystic fibrosis treatment options in Boise, ID, this clinical trial (NCT05504837) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boise research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cystic fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cystic fibrosis clinical trials near you to find additional studies recruiting in your area.

More Cystic Fibrosis Trials in Boise, ID

See all cystic fibrosis clinical trials recruiting in Boise — not just this study.

Browse Cystic Fibrosis Trials in Boise →

Browse More Trials by Condition

Cystic Fibrosis TrialsInterstitial Cystitis TrialsFibromyalgia TrialsAll Conditions →

Ready to Join in Boise?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boise, ID